Jade Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 06/17/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$113.5 | -$74.6 | — | -$81.4 | -$53.2 |
| Net income | -$127.4 | -$69.6 | — | -$75.5 | -$51.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$94.9 | — | — | -$56.9 | -$39.3 |
Shares outstanding 63.6M · Free float 71.8%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.